The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma

Title
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
Authors
Keywords
LSD1, Histone modification, Bone morphogenetic protein 2, SMAD5, NCL-1, Migration
Journal
Acta Neuropathologica Communications
Volume 1, Issue 1, Pages 19
Publisher
Springer Nature
Online
2013-05-29
DOI
10.1186/2051-5960-1-19

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started